HK1153538A1 - Pro-endothelin-1 levels for the prediction of risk of tachyarrhytmic events -1 - Google Patents

Pro-endothelin-1 levels for the prediction of risk of tachyarrhytmic events -1

Info

Publication number
HK1153538A1
HK1153538A1 HK11107630.8A HK11107630A HK1153538A1 HK 1153538 A1 HK1153538 A1 HK 1153538A1 HK 11107630 A HK11107630 A HK 11107630A HK 1153538 A1 HK1153538 A1 HK 1153538A1
Authority
HK
Hong Kong
Prior art keywords
tachyarrhytmic
endothelin
prediction
pro
events
Prior art date
Application number
HK11107630.8A
Other languages
English (en)
Chinese (zh)
Inventor
Joachim Struck
Nils Morgenthaler
Andreas Bergmann
Christian Muller
Original Assignee
Brahms Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brahms Gmbh filed Critical Brahms Gmbh
Publication of HK1153538A1 publication Critical patent/HK1153538A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/5754—Endothelin, vasoactive intestinal contractor [VIC]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/326—Arrhythmias, e.g. ventricular fibrillation, tachycardia, atrioventricular block, torsade de pointes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK11107630.8A 2008-04-04 2011-07-22 Pro-endothelin-1 levels for the prediction of risk of tachyarrhytmic events -1 HK1153538A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08154109A EP2107377A1 (en) 2008-04-04 2008-04-04 Pro-endothelin-1 levels for the prediction of risk of tachyarrhytmic events
PCT/EP2009/053995 WO2009121951A1 (en) 2008-04-04 2009-04-03 Pro-endothelin-1 levels for the prediction of risk of tachyarrhytmic events

Publications (1)

Publication Number Publication Date
HK1153538A1 true HK1153538A1 (en) 2012-03-30

Family

ID=39471708

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11107630.8A HK1153538A1 (en) 2008-04-04 2011-07-22 Pro-endothelin-1 levels for the prediction of risk of tachyarrhytmic events -1

Country Status (7)

Country Link
US (1) US20110111525A1 (xx)
EP (2) EP2107377A1 (xx)
JP (1) JP5442712B2 (xx)
CN (1) CN101984766B (xx)
ES (1) ES2464119T3 (xx)
HK (1) HK1153538A1 (xx)
WO (1) WO2009121951A1 (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8906857B2 (en) * 2005-12-01 2014-12-09 B.R.A.H.M.S. Gmbh Methods for the diagnosis and treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists
US7838250B1 (en) 2006-04-04 2010-11-23 Singulex, Inc. Highly sensitive system and methods for analysis of troponin
EP4357783A2 (en) 2006-04-04 2024-04-24 Novilux, LLC Highly sensitive system and methods for analysis of troponin
EP3358354B1 (en) 2008-01-18 2020-07-15 President and Fellows of Harvard College Methods of detecting signatures of disease or conditions in bodily fluids
AU2010259022B2 (en) 2009-06-08 2016-05-12 Singulex, Inc. Highly sensitive biomarker panels
EP2596349B1 (en) 2010-07-23 2017-12-13 President and Fellows of Harvard College Methods of detecting cardiovascular diseases or conditions
EP2596116A4 (en) 2010-07-23 2014-03-19 Harvard College METHODS FOR DETECTION OF AUTOIMMUNE OR IMMUNE-RELATED DISEASES / PATHOLOGIES
WO2012012693A2 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods for detecting signatures of disease or conditions in bodily fluids
SG10201505724SA (en) 2010-07-23 2015-09-29 Harvard College Methods of detecting diseases or conditions using phagocytic cells
CA2806304A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
US8838224B2 (en) * 2012-03-30 2014-09-16 General Electric Company Method, apparatus and computer program product for predicting ventricular tachyarrhythmias
EP2849729B1 (en) * 2012-05-18 2018-11-14 Critical Care Diagnostics, Inc. Methods for treating or predicting risk of a ventricular tachyarrhythmia event
AU2013273984A1 (en) 2012-06-15 2015-01-22 Harry Stylli Methods of detecting diseases or conditions using circulating diseased cells
EP2861765B1 (en) 2012-06-15 2019-01-23 Progenity, Inc. Methods of detecting diseases or conditions
US8521269B1 (en) 2012-06-27 2013-08-27 Medtronic, Inc. Determining tachyarrhythmia detection parameters based on prior detected episodes
US20140206632A1 (en) * 2013-01-22 2014-07-24 Singulex, Inc. Endothelin in the Diagnosis of Cardiac Disease
NZ771629A (en) 2013-03-09 2022-12-23 Harry Stylli Methods of detecting cancer
WO2014164362A1 (en) 2013-03-09 2014-10-09 Harry Stylli Methods of detecting prostate cancer
WO2016040843A1 (en) 2014-09-11 2016-03-17 Harry Stylli Methods of detecting prostate cancer
WO2016183683A1 (en) * 2015-05-20 2016-11-24 University Health Network Method and system for assessing qrs components and the risk of ventricular arrhythmias
CA3099026A1 (en) 2018-05-04 2019-11-07 University Health Network System and method for assessing qrs components and likelihood of response to cardiac resynchronization therapy
CA3124744A1 (en) * 2019-03-29 2020-10-08 B.R.A.H.M.S Gmbh Prescription of remote patient management based on biomarkers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939272A (en) * 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
IL121659A (en) * 1996-10-25 2000-07-16 Bayer Ag Method for determining CPSA in a blood sample
AU6659298A (en) * 1997-02-18 1998-09-08 Thomas Jefferson University Compositions that bind to pancreatic cancer cells and methods of using the same
JP2007523324A (ja) * 2004-02-05 2007-08-16 メドトロニック・インコーポレーテッド 命にかかわる不整脈のリスク状態にある患者を識別する方法及び装置
JP4976412B2 (ja) * 2005-12-01 2012-07-18 ベー・エル・アー・ハー・エム・エス・ゲーエムベーハー エンドセリン、エンドセリンアゴニスト及びアドレノメジュリンアンタゴニストによる危篤患者の診断及び治療のための方法
DE102006027818A1 (de) * 2006-06-16 2007-12-20 B.R.A.H.M.S. Aktiengesellschaft In vitro Multiparameter-Bestimmungsverfahren zur Diagnose und Frühdiagnose von neurodegenerativen Erkrankungen

Also Published As

Publication number Publication date
JP2011516846A (ja) 2011-05-26
ES2464119T3 (es) 2014-05-30
EP2260307A1 (en) 2010-12-15
US20110111525A1 (en) 2011-05-12
EP2260307B1 (en) 2014-03-26
CN101984766B (zh) 2015-05-13
JP5442712B2 (ja) 2014-03-12
EP2107377A1 (en) 2009-10-07
CN101984766A (zh) 2011-03-09
WO2009121951A1 (en) 2009-10-08

Similar Documents

Publication Publication Date Title
HK1153538A1 (en) Pro-endothelin-1 levels for the prediction of risk of tachyarrhytmic events -1
HK1156638A1 (en) Human anti-alpha-synuclein autoantibodies
EP2309333A4 (en) TONER
EP2287673A4 (en) TONER
EP2249208A4 (en) TONER
EP2249207A4 (en) TONER POWDER
GB201020970D0 (en) Early entry
EP2345935A4 (en) TONER
EP2256557A4 (en) TONER
ZA201104251B (en) Pan section
ZA201102604B (en) Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
GB0921999D0 (en) Early entry
GB0922083D0 (en) Early entry
GB0920030D0 (en) Early entry
EP2289273A4 (en) PREDICTION OF BIT RATE
EP2340037A4 (en) METHOD OF ESTIMATING THE TGF-BETA LEVEL IN A COMPOSITION
GB2457038B (en) Fixing
GB0808977D0 (en) Fixing
GB0800513D0 (en) The right-hand rule of law
PL384973A1 (pl) Sposób otrzymywania erytrytolu
GB201105262D0 (en) Prediction game
GB0806989D0 (en) iTime
ZA201104433B (en) Human anti-alpha-synuclein autoantibodies
GB0811938D0 (en) Pintagram or Drinkagram
PL386672A1 (pl) Sposób kompletowania wkładu zeszytowego